USP30 and Parkinson disease: Collectively, USP30 seems to function by reversing Parkin-mediated ubiquitination of mitochondrial proteins, which subsequently leads to impaired mitophagy, accumulation of depolarized mitochondria, and mitochondrial morphology defects associated with in vitro and in vivo models of PD.